Albertsons Companies, the third-largest US grocer operating under Albertsons, Safeway and other banners, officially withdrew its plans for an initial public offering on Friday.
The Boise, ID-based company was founded in 1926 and booked $59.7 billion in sales for the 12 months ended September 9, 2017. It had planned to list on the NYSE under the symbol ABS. Goldman Sachs, BofA...read more
No US IPOs priced this week. Filing activity remained muted with one Chinese luxury e-commerce company, two micro-cap healthcare deals, and two tech-focused SPACs joining the pipeline, while another mico-cap biotech withdrew. With the"active pipeline" at just 32 IPOs, the mounting backlog of pre-IPO companies (including those in our PCW) continue to delay...read more
Albertsons Companies, the third-largest US grocer operating under Albertsons, Safeway and other banners, reported financial results for the fiscal year ended February 27, 2016, in an amendment filed with the SEC on Wednesday. It set terms to raise $1.6 billion in October 2015 before postponing; its latest filing did not change its proposed terms or disclose a pricing date.
...read more
•Another small-cap biotech is set to kick off Q2 pricings
•Timing of the IPO window reopening is still uncertain, but the pipeline remains robust
First IPO of the second quarterAeglea Biotherapeutics (AGLE), which is developing enzymes for rare genetic metabolic diseases and tumors, is planning to price its $60 million IPO...read more
Albertsons Companies officially withdraws IPO
Albertsons Companies, the third-largest US grocer operating under Albertsons, Safeway and other banners, officially withdrew its plans for an initial public offering on Friday. The Boise, ID-based company was founded in 1926 and booked $59.7 billion in sales for the 12 months ended September 9, 2017. It had planned to list on the NYSE under the symbol ABS. Goldman Sachs, BofA...read more
US IPO Weekly Recap: 5 new filings while summer slowdown in full effect
No US IPOs priced this week. Filing activity remained muted with one Chinese luxury e-commerce company, two micro-cap healthcare deals, and two tech-focused SPACs joining the pipeline, while another mico-cap biotech withdrew. With the "active pipeline" at just 32 IPOs, the mounting backlog of pre-IPO companies (including those in our PCW) continue to delay...read more
Albertsons Companies discloses fiscal 2015 financials ahead of estimated $1.6 billion IPO
Albertsons Companies, the third-largest US grocer operating under Albertsons, Safeway and other banners, reported financial results for the fiscal year ended February 27, 2016, in an amendment filed with the SEC on Wednesday. It set terms to raise $1.6 billion in October 2015 before postponing; its latest filing did not change its proposed terms or disclose a pricing date. ...read more
Week ahead: Small-cap biotech IPO kicks-off Q2
•Another small-cap biotech is set to kick off Q2 pricings •Timing of the IPO window reopening is still uncertain, but the pipeline remains robust First IPO of the second quarter Aeglea Biotherapeutics (AGLE), which is developing enzymes for rare genetic metabolic diseases and tumors, is planning to price its $60 million IPO...read more